Abstract
SPINALLY MEDIATED ANALGESIC INTERACTION BETWEEN MORPHINE AND MIDAZOLAM, CLONIDINE, SEROTONIN, BUPIVACAINE, EPIBATIDINE, NEOSTIGMINE, CARBACHOL, OR BACLOFEN IN RATS: WHICH IS THE MOST EFFECTIVE COMBINATION?

Tomoki Nishiyama MD, PhD*

ABSTRACT

Background: The purpose was to find out the best combination between intrathecal morphine and midazolam, clonidine, serotonin, bupivacaine, epibatidine, neostigmine, carbachol, or baclofen in analgesic effects when intrathecally administered. Methods: Male Sprague-Dawley rats implanted with lumbar intrathecal catheters were given intrathecal combination of morphine and midazolam, clonidine, serotonin, bupivacaine, epibatidine, neostigmine, carbachol, or baclofen, then tail flick test or formalin test was performed. Isobolographic analysis was done using 50 % effective doses (ED50s), and total fractional dose values were calculated. Results: The ED50s of the combination were significantly lower than those of each drug alone in all drugs tested in both tail flick test and formalin test. The ED50 of morphine in the combination was the lowest with baclofen in the tail flick test and with neostigmine in both phases of the formalin test. Total dose fractional value was the lowest with baclofen (0.03) in the tail flick test and with neostigmine (0.006 in phase 1 and 0.00028 in phase 2) in the formalin test. Conclusions: Baclofen for acute thermal pain and neostigmine for inflammatory pain are the best to combine with morphine when intrathecally administered in all tested drugs.

Keywords: Spinal analgesia, morphine, interaction, rat.


[Full Text Article]   [Download Certificate]

Indexing

Best Article Awards

European Journal of Biomedical and Pharmaceutical Sciences (EJBPS) is giving Best Article Award in every Issue for Best Article and Issue Certificate of Appreciation to the Authors to promote research activity of scholar.

Best Article of current issue :

Dr. Dhrubo Jyoti Sen

Download Article : Click here

News & Updation

  • EJBPS: AUGUST ISSUE PUBLISHED

    AUGUST 2026 Issue has been successfully launched on 1 AUGUST 2026.

  • EJBPS: New Impact Factor 2026

    EJBPS Impact Factor has been Increased from  7.482 to 8.181 for Year 2026.

  • Index Copernicus Value

    EJBPS Received Index Copernicus Value 77.3, due to High Quality Publication in EJBPS at International Level

  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.

    .

  • Article Invited for Publication

    Dear Researcher, Article Invited for Publication  in EJBPS coming Issue.

     

Google Scholar Index Copernicus Indian Science Publications Urlich's Periodicals Directory, Proquest, UK (In Process) Research Bible, Fuchu, Tokyo. JAPAN UDLedge Science Citation Index International Society for Research activity (ISRA) Scientific Indexing Services (SIS) InfoBase Index (In Process) SJIF Impact Factor Scholar Article Impact Factor, SAIF Universal Impact Factor CAS (A Division of American Chemical Society) USA (Under Process) Directory of Open Access Journal (DOAJ, Sweden, in process) CiteFactor Directory Of Research Journal Indexing (DRJI) Indian citation Index (ICI) Journal Index (JI, Under Process) Directory of abstract indexing for Journals (DAIJ) Open Access Journals (Under Process) Impact Factor Services For International Journals (IFSIJ) Cosmos Impact Factor Jour Informatics (Under Process) Eurasian Scientific Journal Index (ESJI) International Innovative Journal Impact Factor (IIJIF) Science Library Index, Dubai, United Arab Emirates Global Impact Factor (GIF) (0.377) IP Indexing (IP Value 3.77) Web of Science Group (Under Process) Directory of Research Journals Indexing Scope Database Academia Academia Doi-Digital Online Identifier Doi-Digital Online Identifier ISSN National Centre Zenodo Indexing International CODEN Service, USA

UG/PG/Ph.D Research Publication

Research Scholar of UG/PG/Ph.D can Submit their Research Article/Review Article/Case Study/Short Communication for Publication in EJBPS

Downloads

Copyright From

Covering Letter

                        Author Instruction 
 

PLAGERLUM REPORT